Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06072625
Other study ID # BCH-2023-12/8
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 1, 2023
Est. completion date March 31, 2025

Study information

Verified date October 2023
Source Bursa City Hospital
Contact Ayten Erdogan Ordu, MD
Phone +905389429336
Email aytenli21@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It is a two-arm prospective interventional study. 40 babies in both groups will be enrolment in the study. In the intervention group, babies will take 1 ml/kg/day of the study product (ULTRA PREMIUM) after full enteral feeding. Supplementation will continue until discharge or the 36th week. Blood samples will be taken for serum Total antioxidant capacity and Malondialdehyde levels before the intervention and on the 14th day of the control group. At the end of the study, serum will be taken again for control values. Daily lipid intake amounts will be recorded through breast milk analysis. Lipid profile will be monitored weekly The growth parameters of babies will be monitored daily It will be evaluated at the end of the study in terms of ROP, BPD, and NEC. At the end of the study, the data of babies in both groups will be compared.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 80
Est. completion date March 31, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 14 Days to 40 Days
Eligibility Inclusion Criteria: - Premature babies born at 32 weeks or less - Babies who tolerate full enteral feeding at the before end of the second week - Babies given consent by their parents - Exclusion Criteria: - Having a congenital or genetic anomaly

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Extra virgin organic olive oil (ULTRA PREMIUM)
Babies who have fully enteral feeding will take oral, 1 ml/kg/day of extra virgin olive-oil

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Bursa City Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients who completed the study To enrolment of 40 babies in the study in both groups 15 months
Primary Postnatal growth retardation rates Daily weight intake amounts of babies in both groups 18 months
Secondary Frequency and severity of retinopathy of prematurity Frequency and severity of retinopathy of prematurity 18 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04067973 - Impact of Prematurity on the Optic Nerve
Recruiting NCT05968586 - Non-Invasive Neurally Adjusted Ventilatory Assist (NAVA) Prone vs Supine in Premature Infants N/A
Not yet recruiting NCT05706584 - The Effect of Metaverse-Based Nursing Skills Laboratory N/A
Not yet recruiting NCT05530733 - Clinical Effects of Pacifier Use in Preterm During Orogastric Tube Feeding N/A
Withdrawn NCT04561700 - Nutritive Sucking Patterns in Premature Infants N/A
Recruiting NCT01443273 - Thrombophilic Risk Factors in Preterm and Infants Treated at Ha'Emek Medical Center Between the Years 1990 to 2010
Recruiting NCT04565210 - Effects of Oriental Music on Preterm Infants N/A
Recruiting NCT04866342 - Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor N/A
Enrolling by invitation NCT04168749 - Efficacy and Safety of Industrially Prepared 3 Chamber Bag Parenteral Nutrition for Premature Infant
Recruiting NCT04458441 - Can Warm Skin Disinfection Reduce the Pain Peripheral Central Catheter Application in Premature Babies? N/A
Recruiting NCT05835817 - Magnetoencephalography by Optical Pumping Magnetometer N/A
Enrolling by invitation NCT03061968 - Study of Applying Acupressure in Low-birth Weight Premature N/A
Recruiting NCT06207071 - Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical Trial N/A
Not yet recruiting NCT05806684 - Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.
Recruiting NCT05380401 - Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants N/A
Completed NCT04298346 - Neurological Fate, Prematurity and Genetic Susceptibility Factors
Active, not recruiting NCT05343403 - Parental Participation on the Neonatal Ward - the neoPARTNER Study
Completed NCT04035564 - Early Sodium Intake in Preterm Newborns Phase 4
Recruiting NCT04432636 - Gut Bacteria and Brain of the Baby N/A
Recruiting NCT05301309 - Integrative Early Breastfeeding Support in NICU N/A